Examples of 'eslicarbazepine acetate' in a sentence
Meaning of "eslicarbazepine acetate"
eslicarbazepine acetate - This is a medication used to control seizures in patients with epilepsy. It is a type of antiepileptic drug that works by reducing abnormal electrical activity in the brain
How to use "eslicarbazepine acetate" in a sentence
Basic
Advanced
eslicarbazepine acetate
Haemodialysis removes eslicarbazepine acetate metabolites from plasma.
Eslicarbazepine acetate is extensively converted to eslicarbazepine.
It is unknown whether eslicarbazepine acetate is excreted in human milk.
Eslicarbazepine acetate and methods of use.
The precise mechanisms of action of eslicarbazepine acetate are unknown.
Eslicarbazepine acetate does not affect its own metabolism or clearance.
Zebinix contains the active substance eslicarbazepine acetate.
Eslicarbazepine acetate may decrease the effectiveness of hormonal contraceptives.
The active substance is eslicarbazepine acetate.
Eslicarbazepine acetate metabolites are eliminated from the systemic circulation primarily by renal excretion.
There are no data on the effects of eslicarbazepine acetate on human fertility.
More specifically the invention relates to pharmaceutical preparations containing eslicarbazepine acetate.
The exact way that eslicarbazepine acetate works is unknown.
Frequency of hyponatraemia increased with increasing eslicarbazepine acetate dose.
Genotoxicity studies with eslicarbazepine acetate indicate no special hazards for humans.
See also
Zebinix is a medicine that contains the active substance eslicarbazepine acetate.
The adverse reaction profile of eslicarbazepine acetate is generally similar across age goups.
Moderate hepatic impairment did not affect the pharmacokinetics of eslicarbazepine acetate.
The pharmacokinetics of eslicarbazepine acetate has not been evaluated in patients with severe hepatic impairment.
No cases of serious cutaneous reactions have been reported with eslicarbazepine acetate.
The use of eslicarbazepine acetate in the manufacture of a pharmaceutical composition for treating bipolar disorders.
There are no data from the use of eslicarbazepine acetate in pregnant women.
An increase of the simvastatin dose may be required when used concomitantly with eslicarbazepine acetate.
The use of eslicarbazepine acetate is associated with increase in the PR interval.
Exalief is a medicine that contains the active substance eslicarbazepine acetate.
Eslicarbazepine acetate was developed by the Portuguese pharmaceutical company Bial.
The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.
Similar to adults, eslicarbazepine acetate is extensively converted to eslicarbazepine.
The present disclosure relates to the treatment of diabetic neuropathic pain with eslicarbazepine acetate.
Eslicarbazepine acetate is extensively converted to eslicarbazepine, which is mainly eliminated by glucuronidation.
The present disclosure relates to the treatment of post herpetic neuralgia with eslicarbazepine acetate.
The use of eslicarbazepine acetate in the manufacture of a pharmaceutical composition for treating post-herpetic neuralgia.
Prolongations in PR interval have been observed in clinical studies with eslicarbazepine acetate.
Eslicarbazepine acetate metabolites can effectively be cleared by haemodialysis, if necessary see section 5.2.
No second or higher degree AV block was seen in eslicarbazepine acetate treated patients.
Eslicarbazepine acetate is absorbed to at least 90 % from the gut, independently of food intake.
If clinically-relevant hyponatraemia develops, eslicarbazepine acetate should be discontinued.
More specifically the invention relates to pharmaceutical compositions containing licarbazepine acetate, especially eslicarbazepine acetate.
If signs or symptoms of hypersensitivity develop, eslicarbazepine acetate must be discontinued.
Studies in animals have shown impairment of fertility after treatment with eslicarbazepine acetate ( see section 5.3 ).
Therefore, their occurrence after treatment with eslicarbazepine acetate can not be excluded.
In children from 2 to 6 years of age, the use of eslicarbazepine acetate is not recommended.
Each tablet contains 200 mg of eslicarbazepine acetate.
Each tablet constains 800 mg of eslicarbazepine acetate.
Only a few subjects ( N=27 ) aged above 65 years were treated with eslicarbazepine acetate in monotherapy study.
You'll also be interested in:
Examples of using Acetate
Show more
Phenylmercuric acetate and similar mercury compounds
Cellulose nitrate and cellulose acetate are unstable
Abiraterone acetate was not carcinogenic in female rats
